AnaptysBio Inc
NASDAQ:ANAB

Watchlist Manager
AnaptysBio Inc Logo
AnaptysBio Inc
NASDAQ:ANAB
Watchlist
Price: 14.535 USD -0.1%
Market Cap: 442.3m USD
Have any thoughts about
AnaptysBio Inc?
Write Note

P/OCF
Price to OCF

-4.3
Current
-7.4
Median
21.9
Industry
Higher than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-4.3
=
Market Cap
426.3m USD
/
Operating Cash Flow
-103m USD
All Countries
Close
Market Cap P/OCF
US
AnaptysBio Inc
NASDAQ:ANAB
426.3m USD -4.3
FR
Pharnext SCA
OTC:PNEXF
6T USD -238 967.6
US
Abbvie Inc
NYSE:ABBV
311.8B USD 18.8
US
Amgen Inc
NASDAQ:AMGN
140.7B USD 19.4
US
Gilead Sciences Inc
NASDAQ:GILD
115.7B USD 11.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
102.7B USD -122.2
US
Epizyme Inc
F:EPE
94.1B EUR -470.8
AU
CSL Ltd
ASX:CSL
134.4B AUD 30.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78B USD 18.5
US
Seagen Inc
F:SGT
39.3B EUR -76
NL
argenx SE
XBRU:ARGX
36B EUR -144.7
 
US
AnaptysBio Inc
NASDAQ:ANAB
Average P/OCF: 19.7
Negative Multiple: -4.3
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -238 967.6
US
Abbvie Inc
NYSE:ABBV
18.8
US
Amgen Inc
NASDAQ:AMGN
19.4
US
Gilead Sciences Inc
NASDAQ:GILD
11.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -122.2
US
E
Epizyme Inc
F:EPE
Negative Multiple: -470.8
AU
CSL Ltd
ASX:CSL
30.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.5
US
S
Seagen Inc
F:SGT
Negative Multiple: -76
NL
argenx SE
XBRU:ARGX
Negative Multiple: -144.7

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A

See Also

Discover More